Zhenhong Su

Huangshi, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Immersive ethical role-play in undergraduate nursing ethics education: a qualitative descriptive study.

Immersive ethical role-play in undergraduate nursing ethics education: a qualitative descriptive study.

Journal: BMC medical ethics

Published: April 09, 2026

Chalcone-containing dual-targeting PD-L1/tubulin small molecules: a novel approach for cancer immunotherapy.

Chalcone-containing dual-targeting PD-L1/tubulin small molecules: a novel approach for cancer immunotherapy.

Journal: Frontiers in pharmacology

Published: November 06, 2025

Novel imidazo[1,2-a]pyridine-based tubulin polymerization inhibitors: Structure-activity relationships and anti-tumor immune potentiation.

Novel imidazo[1,2-a]pyridine-based tubulin polymerization inhibitors: Structure-activity relationships and anti-tumor immune potentiation.

Journal: European journal of medicinal chemistry

Published: September 23, 2025

Novel Dichloroacetophenone-Based PDHK1 Inhibitors as Potent Anticancer Agents.

Novel Dichloroacetophenone-Based PDHK1 Inhibitors as Potent Anticancer Agents.

Journal: Drug design, development and therapy

Published: July 02, 2024

Discovery of Small and Bifunctional Molecules Targeting PD-L1/CD73 for Cancer Dual Immunotherapy.

Discovery of Small and Bifunctional Molecules Targeting PD-L1/CD73 for Cancer Dual Immunotherapy.

Journal: Journal of medicinal chemistry

Published: May 15, 2024

Recent Progress in DNA Damage Response-Targeting PROTAC Degraders.

Recent Progress in DNA Damage Response-Targeting PROTAC Degraders.

Journal: Journal of medicinal chemistry

Published: April 25, 2024

Lactoferrin/CD133 antibody conjugated nanostructured lipid carriers for dual targeting of blood-brain-barrier and glioblastoma stem cells.

Lactoferrin/CD133 antibody conjugated nanostructured lipid carriers for dual targeting of blood-brain-barrier and glioblastoma stem cells.

Journal: Biomedical materials (Bristol, England)

Published: April 09, 2024

Discovery of Novel Heterotricyclic Compounds as DNA-Dependent Protein Kinase (DNA-PK) Inhibitors with Enhanced Chemosensitivity, Oral Bioavailability, and the Ability to Potentiate Cancer Immunotherapy.

Discovery of Novel Heterotricyclic Compounds as DNA-Dependent Protein Kinase (DNA-PK) Inhibitors with Enhanced Chemosensitivity, Oral Bioavailability, and the Ability to Potentiate Cancer Immunotherapy.

Journal: Journal of medicinal chemistry

Published: April 08, 2024

HDAC-targeting epigenetic modulators for cancer immunotherapy.

HDAC-targeting epigenetic modulators for cancer immunotherapy.

Journal: European journal of medicinal chemistry

Published: December 04, 2023

Breviscapine alleviates myocardial ischemia-reperfusion injury in diabetes rats.

Breviscapine alleviates myocardial ischemia-reperfusion injury in diabetes rats.

Journal: Acta cirurgica brasileira

Published: July 06, 2023

From design to clinic: Engineered peptide nanomaterials for cancer immunotherapy.

From design to clinic: Engineered peptide nanomaterials for cancer immunotherapy.

Journal: Frontiers in chemistry

Published: November 25, 2022

A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma.

A miR-9-5p/FOXO1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma.

Journal: Cells

Published: May 20, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026